Dr. Lars Gnägi

Lars studied chemistry at the university of Bern, Switzerland. After an internship at Actelion Pharmaceuticals Ltd. in Basel, he returned to Bern for his PhD under the supervision of Philippe Renaud working on natural product synthesis, peroxide-based radical initiators, and studied the mechanism of the Schmidt rearrangement. Lars joined the Schoenebeck group in October 2021.